| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |